Access brought to you by: LOCKSS
Login
GIST Survival: Imatinib Versus Doxorubicin.
GIST=gastrointestinal stromal tumor.
Reprinted from Verweij J et al. Progression-free Survival in Gastrointestinal Stromal Tumours with High-Dose Imatinib: Randomised Trial. The Lancet;364(9440):1127–34. Copyright 2004, with permission from Elsevier.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.